François Alla

Author PubWeight™ 67.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 7.99
2 Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015 6.13
3 Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002 4.48
4 Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003 3.41
5 Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 2012 2.02
6 Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012 1.97
7 Ethics and observational studies in medical research: various rules in a common framework. Int J Epidemiol 2009 1.85
8 Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases. Diabetes Care 2012 1.76
9 Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV 2016 1.51
10 Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol 2014 1.51
11 Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011 1.51
12 Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology 2010 1.50
13 Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006 1.45
14 Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J 2006 1.43
15 The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 2009 1.14
16 Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010 1.11
17 Letter by Duval et al regarding article, "Incidence of Infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines". Circulation 2013 1.07
18 Heart failure burden and therapy. Europace 2009 0.97
19 In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007 0.96
20 A tool to analyze the transferability of health promotion interventions. BMC Public Health 2013 0.91
21 Transferability of interventions in health education: a review. BMC Public Health 2012 0.90
22 Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study. Transpl Int 2008 0.89
23 Left bundle branch block and mortality in patients with acute heart failure syndrome: a substudy of the EFICA cohort. Eur J Heart Fail 2009 0.89
24 Clinical and microbiologic features of multivalvular endocarditis. Curr Infect Dis Rep 2010 0.89
25 Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 2004 0.88
26 Teaching ethics in Europe. J Med Ethics 2007 0.88
27 Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses. Eur J Cardiothorac Surg 2009 0.86
28 Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study. Fundam Clin Pharmacol 2012 0.84
29 Evaluating complex interventions: perspectives and issues for health behaviour change interventions. Psychol Health 2014 0.83
30 Comparative evaluation of schistocyte counting by an automated method and by microscopic determination. Am J Clin Pathol 2004 0.83
31 Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin. Pharmacoepidemiol Drug Saf 2015 0.83
32 Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure. Eur J Heart Fail 2007 0.81
33 The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One 2013 0.80
34 Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality. BMC Urol 2014 0.80
35 Correlation between peripheral blood pressure and pulse-wave velocity values in the institutionalized elderly persons 80 years of age and older: the PARTAGE study. Am J Hypertens 2012 0.80
36 First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up. Arch Cardiovasc Dis 2013 0.79
37 TABADO: "evaluation of a smoking cessation program among adolescents in vocational training centers": study protocol. BMC Public Health 2009 0.78
38 Effectiveness of a multidimensional home nurse led heart failure disease management program--a French nationwide time-series comparison. Int J Cardiol 2013 0.78
39 Nonischemic dilated cardiomyopathy: results of noninvasive and invasive evaluation in 310 patients and clinical significance of bundle branch block. Pacing Clin Electrophysiol 2008 0.78
40 [Psychotropic drug consumption and compliance: mutual patient and general practitioner therapeutic implication]. Presse Med 2004 0.78
41 [Knowledge brokering: definition and application based on a review of the literature]. Sante Publique 2014 0.78
42 The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality. Med Care 2016 0.78
43 Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database. Pharmacoepidemiol Drug Saf 2013 0.78
44 The prognostic value of circulating markers of collagen turnover after acute myocardial infarction. Int J Cardiol 2010 0.77
45 Efficacy of a smoking cessation program in a population of adolescent smokers in vocational schools: a public health evaluative controlled study. BMC Public Health 2013 0.77
46 [Transfer and sharing of public health knowledge: reflections on the components of a national information system in France]. Sante Publique 2014 0.77
47 Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysis. Am J Respir Cell Mol Biol 2002 0.77
48 Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation. Clin Transplant 2008 0.77
49 [Governance: concept and debates]. Sante Publique 2008 0.76
50 Impact of heart failure management unit on heart failure-related readmission rate and mortality. Arch Cardiovasc Dis 2010 0.76
51 Association of current weight and birth weight with blood pressure levels in Saharan and European teenager populations. Am J Hypertens 2010 0.76
52 Residual stress ischaemia is associated with blood markers of myocardial structural remodelling. Eur J Heart Fail 2006 0.75
53 Effectiveness of a multidisciplinary heart failure disease management programme on 1-year mortality: Prospective cohort study. Medicine (Baltimore) 2016 0.75
54 Socioeconomic factors and mortality in diastolic heart failure. Eur J Clin Invest 2014 0.75
55 [Betting on a simpler review process]. Sante Publique 2008 0.75
56 [Evidence based public health: learning to decide]. Sante Publique 2007 0.75
57 Thawed autologous peripheral blood stem cells require modified quantification methods for hematopoietic progenitor cell evaluation. Biomed Mater Eng 2012 0.75
58 [Issues and practices in health education]. Sante Publique 2013 0.75
59 Analysis of patient claims related to care in a university cardiology department over the period 2003-2007. Arch Cardiovasc Dis 2010 0.75
60 [Scientific publishing: an absolute must for public health professionals]. Sante Publique 2007 0.75
61 [The case for a new French public health law at the service of a fairer and more effective national health policy]. Sante Publique 2012 0.75
62 [Promoting prevention policy]. Sante Publique 2012 0.75
63 [A tool to facilitate transferability of health promotion interventions: ASTAIRE]. Sante Publique 2015 0.75
64 [Occupational health: a challenge for public health?]. Sante Publique 2008 0.75
65 Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study. Eur J Cancer Prev 2017 0.75
66 [In Process Citation]. Sante Publique 2016 0.75
67 [ASTAIRE: Tool for the analysis of the transferability and facilitation of the adaptation of interventions in health promotion, V2-2014]. Sante Publique 2015 0.75
68 [Creating a shared culture of health promotion and health care]. Sante Publique 2013 0.75
69 [Should the Ottawa Charter still be the reference 30 years later?] Sante Publique 2016 0.75
70 [Complexity: concept and challenges for public health interventions]. Sante Publique 2017 0.75
71 [Letter to the editor]. Sante Publique 2008 0.75
72 Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010. Arch Cardiovasc Dis 2013 0.75
73 [Health education: the poor relation of health policy?]. Sante Publique 2013 0.75
74 Sante Publique 2017 0.75
75 Single acceleromyographic train-of-four, 100-Hertz tetanus or double-burst stimulation: which test performs better to detect residual paralysis? Anesthesiology 2005 0.75
76 [Access to Sante Publique via CAIRN]. Sante Publique 2008 0.75
77 Does pre-emptive kidney transplantation with a deceased donor improve outcomes? Results from a French transplant network. Transpl Int 2010 0.75
78 [The center of biological ressources for the lung cancer]. Bull Cancer 2004 0.75